Efficacy of coronary angioplasty for the treatment of hibernating myocardium

Heart

Volumn 82, Issue 2, 1999, Pages 210-216

  Fath Ordoubadi, F ^a   Beatt, K J ^a   Spyrou, N ^a   Camici, P G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Myocardial blood flow; Myocardial hibernation; Percutaneous transluminal coronary angioplasty; Positron emission tomography

Indexed keywords

DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F 18; OXYGEN 15;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; FEMALE; HEART VENTRICLE WALL MOTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0032791272     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.2.210     Document Type: Article

References (50)

1. Gruentzig AR, Senning A, Siegenthaler WE. Non-operative dilatation of coronary artery stenosis. N Engl J Med 1979;301:1-8.
2. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
3. DiSciascio G, Cowley MJ, Vetrovec GW, et al. Triple vessel coronary angioplasty: acute outcome and long term results. J Am Coll Cardiol 1988;12:42-8.
4. Rahimtoola SH. A prospective on three large multicenter randomised clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72(suppl V): V1230-5.
5. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
6. Tamaki N, Yonckura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deexyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
7. Lucignani G, Paolini G, Landoni C, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease, Eur J Nucl Med 1992;19:874-81.
8. Shivalkar B, Maes A, Borgers M, et al. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation 1996;94:308-15
9. Di Carli M, Asgarzadie F, Schelbert H, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:34366-44.
10. vom Dahl J, Eitzman DT, al Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.
11. Tamaki N, Kawamoto M, Takahashi N, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993;22:1621-7.
12. Tamaki N, Kawamoto M, Tadamura E, et al. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
13. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994; 90:2687-94.
14. Marwick TH, MacIntyre WJ, Lafont A, et al. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism. Circulation 1992;85:1347-53.
15. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22: 1587-97.
16. Knuuti MJ, Saraste M, Nuutila P, et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994;127:785-96.
17. Eitzman D, al Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
18. Nienaber CA, Brunken RC, Sherman CT, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18:966-78.
19. Afridi I, Kleiman NS, Raizner AE, et al. Dobutamine echo-cardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
20. Berger PB, Holmes DR, Ohman EM, et al. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the multicenter American research trial writh cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (MARCATOR), J Am Coll Cardiol 1996;27:1-7.
21. Holmes DR, Vallbracht C, Kadel C. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cordial 1984;53:77-81c.
22. Popma JJ, Topol EJ. Factors influencing restenosis after coronary angioplasty. Am J Med 1990;88:16-24N.
23. Schiller NB. Committee of standards, subcommittee on quantification of two-dimensional echocardiograms. Recommendation for quantification of the left ventricle two-dimensional echocardiography. J Am Soc Echocardiogr 1989;5:358-67.
24. De Fronzo RA, Jordan DT, Reubin A. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-23.
25. Marinho NVS, Keogh BE, Costa DC, et al. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization, Circulation 1996;93:737-44.
26. Spinks TJ, Jones T, Gilardi MC, et al. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci 1988;35:721-5.
27. Araujo LI, Lammerstma AA, Rhodes CG, et al. Non-invasive quantification of regional myocardial blood flow in normal volunteers and patients with coronary artery disease using oxygen-15 labelled carbon dioxide and positron emission tomography. Circulation 1991;83:875-85.
28. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Science, 1994.
29. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985 1986 and 1977-1981, The National Heart, Lung, and Blood Institute Registry. N Engl J Med 1988;318:265-70.
30. vom Dahl J, Uebis R, Sheehan FH, et al. Factors influencing outcome of regional wall motion following percutaneous transluminal angioplasty. Coronary Artery Dis 1992;3:489-98.
31. Melgares R, Prieto JA, Azpitarte J. Significant coronary restenosis limits the recovery of regional left ventricular myocardial dysfunction achieved after successful coronary angioplasty. Eur Heart J 1993;14:886-75.
32. Miketic S, Carlsson J, Tebbe U. Improvement of global and regional left ventricular function by percutaneous transluminal coronary angioplasty after myocardial infarction, J Am Coll Cardiol 1995; 25:84.3-7.
33. vom Dahl J, Altehoefer C, Shechan FH, et al. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948-58.
34. Tamaki N, Yonekura Y, Konishi J. Myocardial FDG PET studies with the fasting, oral glucose-loading or insulin clamp methods. J Nucl Med 1992;33:1263-8.
35. Schelbert HR. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilisation during positron emission tomography. J Nucl Med 1992;33: 1263-6.
36. Paternostro G, Camici PG, Lammerstma AA, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996;98:2094-9.
37. Maddahi J, Schelbert H, Brunken R, et al. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. J Nucl Med 1994;35:707-15.
38. Ausma J, Furst D, Thone F, et al. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation. J Mol Cell Cardiol 1995;27:1203-12.
39. Ausma J, Cleutjens J, Thone F, et al. Chronic hibernating myocardium; interstitial changes. Mol Cell Biochem 1995; 147:35-42.
40. Vanoverschelde JL, Janier MF, Bakke JE, et al. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994;267:H1758-94.
41. Vignola P, Boucher C, Curfman G. Abnormal interventricular septal motion following cardiac surgery: clinical, surgical, echocardiographic and radionuclide correlates. Am Heart J 1979;97:27-34.
42. Okada RD, Murphy JH, Boucher CA, et al. Relationship between septal perfusion, viability, and motion before and after coronary artery bypass surgery. Am Heart J 1992;124: 1190-5.
43. Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996;94:651-9.
44. Vanoverschelde JL, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfareted collateral-dependent myocardium. Circulation 1993;87:1513-23.
45. Maki M, Luotolahti M, Nuutila P. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658-6.
46. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994;330:1782-8.
47. Bergmann SR, Herrero P, Markham J, et al. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989;14:639-52.
48. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res 1995;76:479-88.
49. Camici PG, Wijns WC, Borgers M, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997; 96: 3205-14.
50. Wijns W, Vatner SF, Camici PG. Chronic reversible left ventricular dysfunction in patients with coronary artery disease a.k.a. hibernating myocardium. N Engl J Med 1998; 339:173-81.